“revolutionising healthcare through continuously improving diagnostic solutions”

RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME

• The worlds largest global EQA scheme in the world – Large database of users – 22 flexible EQA programmes– Accredited to ISO/IEC 17043:2010– Comprehensive yet user friendly reports – Highest quality materials– Regular reporting (Bi-weekly/Monthly)– Rapid report turnaround (1-3 days from final submission date)– Consolidation – reduce the number of programmes required– Flexible options available to suit all laboratory sizes and budgets– Register up to 5 separate instruments at no extra cost and receive complimentary multi-

instrument report – Free interlaboratory report available to lab chains or groups– Certificates of participation provided at the end of each cycle– End-of-cycle reports provided – Submit results and view reports online via RIQAS.Net

The World’s Largest Global EQA Scheme

Over 24, 000 laboratory participants

More than 105 countries worldwide

Larger peer groups more statistically relevant data

Wider range of instruments and methods covered

22 Flexible EQA Programmes• BNP• Clinical Chemistry • Immunoassay • Specific Proteins• Liquid Cardiac • Cardiac• Coagulation • Blood Gas• Urinalysis• Maternal Screening• Lipids

• Urine Toxicology• Human Urine• HbA1c • Immunoassay Speciality I • Immunoassay Speciality II • Haematology • Therapeutic Drugs • Serology EBV• Serology HIV/Hepatitis• Serology ToRCH• Serology Syphilis

Internationally Accredited

• RIQAS is internationally accredited to the following standards– ISO/IEC 17043:2010– ISO 13485– UKAS– UK National Quality Assurance Advisory Panel

(NQAAP)– Joint Working Group on Quality Assurance

(JWQ QA)

User Friendly Reports• RIQAS reports are presented in a convenient one page per

parameter format with the following features:– Compare results to all methods, method group and instrument group – Compare to RIQAS default limits or user defined limits e.g. CLIA or

Biological variation – Levey-Jennings charts displaying results for last 20 samples– Unique target score chart allowing at a glance assessment – % deviation by concentration chart for rapid assessment of concentration

related bias– Histogram charts comparing performance to peers, all methods, method

group and instrument group can be viewed on one chart– Multi-method stat section allows you to assess the performance of other

methods – Summary page conveniently highlighting any poor performing tests at a

glance

Standard RIQAS Report

Summary Page

Parameter Report

End-of Cycle Reports

• End-of-cycle reports– Provided at the end of each cycle and contain a

summary of all statistics – Compare performance to the previous cycle– Compare to laboratories worldwide or in your

country only – Text and graphical representation– Certificate of performance listing all parameters for

which your lab achieved acceptable performance provided

End-of-Cycle Reports

Multi-Instrument Reports

• Laboratories can register up 5 instruments for each parameter at no extra cost – Individual reports for each instrument are

supplied in addition to a complimentary unique multi-instrument report

– Allows comparative performance assessment of each instrument

Interlaboratory Reports

• Ideal for laboratory groups and chains

• Allows comparative performance assessment of multiple connected laboratories

• Available at no extra cost to participating laboratories

Highest Quality Samples

• All RIQAS samples are designed to mirror the performance of patient samples – 100% human samples for immunoassay methods– Free from interfering preservatives/stabilisers– Covers a range of concentrations

Frequent Reporting

• RIQAS offers monthly or bi-weekly reporting – Identify system errors sooner – Cover a range of clinically significant

concentrations sooner – Allows laboratories to take corrective and

preventative actions sooner with minimum disruption to laboratory output

– Can be used to complement national EQA schemes

RIQAS Clinical Chemistry Programme• Designed to monitor the performance of 50 parameters including routine

chemistries, lipids, hormones and trace metals

• Contains routinely run thyroid hormones in addition to PSA meaning it can even be used by small labs to cover their full immunoassay menu

• Three flexible yet cost effective programme options available– Choose any 10 parameters– Choose any 17 parameters– Choose all 50 parameters

• Bi-weekly reporting

• Reference method values available for 12 parameters

RIQAS Immunoassay Programme • Designed to monitor up to 55 parameters including therapeutic

drugs, hormones, tumour markers and Vitamin D

• 4 flexible yet cost effective programme options available – Choose any 4 parameters– Choose any 13 parameters– Choose all 55 parameters– Choose all 55 parameters (monthly reporting)

• Choice of bi-weekly or monthly reporting

• 100% human samples

Immunoassay Speciality I + II • Immunoassay Speciality I

– Designed to monitor 10 specialised immunoassay parameters including Procalcitonin and Vitamin D

– 100% human serum – Monthly reporting

• Immunoassay Speciality II– Designed to monitor 5 complex, specialised immunoassay parameters – 100% human serum – Monthly reporting

Only EQA scheme to offer Procalcitonin

Haematology Programme • Designed to monitor the performance of 12 haematology

parameters

• Liquid ready-to-use samples for ease of use and convenience

• 100% whole blood samples

• Samples provided in primary tubes for convenience

• Bi-weekly reporting

Serology Programmes • 4 serology programmes

– Epstein Barr Virus (3 parameters)– HIV/Hepatitis (10 parameters)– ToRCH (12 parameters)– Syphilis

• Liquid ready to use samples for ease of use and convenience

• Quarterly reporting

• Free from interfering infectious components

Interested in RIQAS? Hear from one of new users.

• Large database of users• 22 flexible EQA programmes• Accredited to ISO/IEC 17043:2010• Comprehensive yet user friendly reports • Highest quality materials• Regular reporting (Bi-weekly/Monthly)• Rapid report turnaround (1-3 days from final submission date)• Consolidation – reduce the number of programmes required• Flexible options available to suit all laboratory sizes and budgets• Register up to 5 separate instruments at no extra cost and receive

complimentary multi-instrument report • Free interlaboratory report available to lab chains or groups• Certificates of participation provided at the end of each cycle• End-of-cycle reports provided • Submit results and view reports online via RIQAS.Net

Summary

Visit our website www.riqas.com

Contact Us Acusera@randox.com

“revolutionising healthcare through continuously improving diagnostic solutions”